5 Mounjaro subcutaneous injection, Rx only, has not been approved by the FDA as safe and effective to treat obesity or overweight, however studies have shown that it may be associated with weight loss in individuals with type 2 diabetes
The treatment of choice for MNTI is excision, and it is usually curative
In the phase 3 ACHIEVE-3 trial , adults with type 2 diabetes inadequately controlled by metformin were randomized to receive orforglipron or oral semaglutide (7 mg and 14 mg, doses approved for type 2 diabetes)
Nayan (16:46) Absolutely, and this is, I mean, I see patients, I work with all the providers at Thrivelab, I work with them on a daily basis, and we see this manifestation of oxidative stress comes up in various forms, right